The cox regression test outcomes (Table 3) indicated that increased expression of AURKA gene was associated with a poor prognosis in the bladder (BLCA), kidney (KIRC), liver (LIHC), lung (LUAD), prostate (PAAD), and uterine cancer (UCEC). Here, AURKA is linked to bladder transitional cell carcinoma.